Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 11.8M | 12.2M | 14.8M | 14.0M |
Selling general and admin | 4.0M | 3.6M | 3.3M | 3.3M |
Other operating expenses | — | — | — | — |
Operating income | -15.8M | -15.8M | -18.1M | -17.3M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 892K | 852K | 882K | 1.0M |
Pretax income | -14.9M | -15.0M | -17.3M | -16.3M |
Tax provision | — | — | — | — |
Net income | -14.9M | -15.0M | -17.3M | -16.3M |
Basic EPS | -0.2 | -0.2 | -0.2 | -0.2 |
Diluted EPS | -0.2 | -0.2 | -0.2 | -0.2 |
Basic average shares | 86.5M | 82.7M | 75.8M | 72.3M |
Diluted average shares | 86.5M | 82.7M | 75.8M | 72.3M |
EBITDA | -15.4M | -15.8M | -17.8M | -16.9M |
Net income from continuing op. | -14.9M | -15.0M | -17.3M | -16.3M |
Minority interests | 1K | 1K | 2K | 0 |
Preferred stock dividends | — | — | — | — |